Enric Carreras

16.2k total citations
255 papers, 8.4k citations indexed

About

Enric Carreras is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Enric Carreras has authored 255 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Hematology, 65 papers in Oncology and 43 papers in Genetics. Recurrent topics in Enric Carreras's work include Hematopoietic Stem Cell Transplantation (126 papers), Acute Myeloid Leukemia Research (61 papers) and Neutropenia and Cancer Infections (25 papers). Enric Carreras is often cited by papers focused on Hematopoietic Stem Cell Transplantation (126 papers), Acute Myeloid Leukemia Research (61 papers) and Neutropenia and Cancer Infections (25 papers). Enric Carreras collaborates with scholars based in Spain, Germany and United States. Enric Carreras's co-authors include Montserrat Rovira, Maribel Díaz‐Ricart, Carmen Martı́nez, Francesc Fernández‐Avilés, Jorge Sierra, C Rozmán, Mohamad Mohty, Álvaro Urbano-Ispizúa, Nicolaus Kröger and Aloïs Gratwohl and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Enric Carreras

244 papers receiving 8.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enric Carreras Spain 52 5.1k 2.2k 1.6k 1.4k 1.2k 255 8.4k
Christina Peters Austria 48 4.1k 0.8× 2.1k 1.0× 1.2k 0.7× 1.1k 0.7× 2.2k 1.9× 242 8.2k
Georgia B. Vogelsang United States 54 6.9k 1.4× 1.9k 0.9× 3.2k 2.1× 1.8k 1.3× 1.4k 1.3× 141 10.4k
Karen K. Ballen United States 45 5.8k 1.1× 2.1k 0.9× 1.9k 1.2× 1.9k 1.3× 1.8k 1.5× 234 8.1k
Michael B. Maris United States 50 7.8k 1.5× 2.8k 1.3× 2.5k 1.6× 1.6k 1.2× 2.3k 2.0× 173 11.0k
Howard M. Shulman United States 53 7.8k 1.5× 2.0k 0.9× 2.4k 1.6× 1.3k 0.9× 1.7k 1.4× 109 11.3k
Marcelo C. Pasquini United States 46 5.3k 1.0× 2.3k 1.1× 1.7k 1.1× 919 0.6× 1.6k 1.4× 246 7.6k
Christopher Bredeson Canada 46 4.5k 0.9× 1.9k 0.9× 1.0k 0.7× 1.3k 0.9× 1.6k 1.4× 170 6.7k
Linda J. Burns United States 46 3.8k 0.7× 3.2k 1.5× 2.8k 1.8× 1.0k 0.7× 1.2k 1.1× 197 7.7k
Mohamed L. Sorror United States 46 8.4k 1.6× 2.8k 1.3× 1.9k 1.2× 2.1k 1.5× 2.9k 2.5× 160 10.9k
Madan Jagasia United States 43 5.1k 1.0× 1.6k 0.7× 1.9k 1.2× 1.3k 0.9× 1.6k 1.3× 251 7.2k

Countries citing papers authored by Enric Carreras

Since Specialization
Citations

This map shows the geographic impact of Enric Carreras's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enric Carreras with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enric Carreras more than expected).

Fields of papers citing papers by Enric Carreras

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enric Carreras. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enric Carreras. The network helps show where Enric Carreras may publish in the future.

Co-authorship network of co-authors of Enric Carreras

This figure shows the co-authorship network connecting the top 25 collaborators of Enric Carreras. A scholar is included among the top collaborators of Enric Carreras based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enric Carreras. Enric Carreras is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Youssef, L., Patricia Molina, Julia Martínez-Sánchez, et al.. (2025). Endothelial damage and complement dysregulation in fetuses from pregnancies complicated by preeclampsia. Acta Obstetricia Et Gynecologica Scandinavica. 104(5). 829–838. 2 indexed citations
2.
Guijarro, Francesca, Mònica López‐Guerra, Laura Rosiñol, et al.. (2024). Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group. British Journal of Haematology. 205(1). 256–267. 5 indexed citations
3.
Suárez‐Lledó, María, Cristina Moreno, Joan Cid, et al.. (2024). Outcomes of older adults undergoing allogeneic hematopoietic cell transplantation with post‐transplant cyclophosphamide based prophylaxis. European Journal Of Haematology. 113(6). 765–775.
4.
Pedraza, Alexandra, María Queralt Salas, Luis Gerardo Rodríguez‐Lobato, et al.. (2023). Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation. Transplantation and Cellular Therapy. 30(2). 187.e1–187.e12. 22 indexed citations
5.
Martínez-Sánchez, Julia, Marta Palomo, Alexandra Pedraza, et al.. (2023). Differential protein expression in endothelial cells exposed to serum from patients with acute graft‐vs‐host disease, depending on steroid response. Journal of Cellular and Molecular Medicine. 27(9). 1227–1238. 3 indexed citations
6.
Martínez-Sánchez, Julia, Marta Palomo, Ana Belén Moreno‐Castaño, et al.. (2023). Mafosfamide, a cyclophosphamide analog, causes a proinflammatory response and increased permeability on endothelial cells in vitro. Bone Marrow Transplantation. 58(4). 407–413. 5 indexed citations
7.
Salas, María Queralt, Alexandra Pedraza, María Suárez‐Lledó, et al.. (2023). Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations. Transplantation and Cellular Therapy. 30(2). 213.e1–213.e12. 5 indexed citations
8.
Moreno‐Castaño, Ana Belén, Sara Fernández, Marta Palomo, et al.. (2023). Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis. Journal for ImmunoTherapy of Cancer. 11(4). e006365–e006365. 15 indexed citations
9.
Palomo, Marta, L. Youssef, Sergi Torramadé‐Moix, et al.. (2022). Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy. American Journal of Obstetrics and Gynecology. 227(2). 277.e1–277.e16. 23 indexed citations
10.
Fernández, Sara, Marta Palomo, Patricia Molina, et al.. (2021). Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contender. Journal of Thrombosis and Haemostasis. 19(8). 1948–1958. 15 indexed citations
11.
Blasco, Miquel, Elena Guillén, Luís F. Quintana, et al.. (2020). Thrombotic microangiopathies assessment: mind the complement. Clinical Kidney Journal. 14(4). 1055–1066. 17 indexed citations
12.
Barberán, José, Juan J. Picazo, Emilio Bouza, et al.. (2008). Guía de tratamiento de la infección producida por Staphylococcus aureus resistente a meticilina. Revista española de quimioterapia. Suplemento. 21(4). 234–258. 26 indexed citations
13.
Granell, Miquel, Álvaro Urbano-Ispizúa, Juan I. Aróstegui, et al.. (2006). Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation.. PubMed. 91(10). 1372–6. 51 indexed citations
14.
Atala, Jorge, Jordi Blanch, Enric Carreras, et al.. (2005). Role of Depression As a Predictor of Mortality Among Cancer Patients After Stem-Cell Transplantation. Journal of Clinical Oncology. 23(25). 6063–6071. 144 indexed citations
15.
Carreras, Enric, Mónica Jiménez, Rafael de la Cámara, et al.. (2005). Donor age and degree of HLA matching have a major impact on the outcome of unrelated donor haematopoietic cell transplantation for chronic myeloid leukaemia. Bone Marrow Transplantation. 37(1). 33–40. 44 indexed citations
16.
Carreras, Enric, et al.. (2004). Dues tombes romanes a Llafranc. RACO (Revistes Catalanes amb Accés Obert) (Consorci de Serveis Universitaris de Catalunya). 25–36. 1 indexed citations
17.
Szydlo, Richard, Maria Gilleece, Gunnar Juliusson, et al.. (2002). Reduced intensity conditioned allografts for myeloma : A study from the Chronic Leukaemia Working Party of the EBMT.. Blood. 100(11). 542. 1 indexed citations
18.
Briones, Javier, Álvaro Urbano-Ispizúa, C Rozmán, et al.. (1996). Study of hematopoietic chimerism following allogeneic peripheral blood stem cell transplantation using PCR amplification of short tandem repeats. Annals of Hematology. 72(4). 265–268. 13 indexed citations
19.
Pau, Carles Roqué i, et al.. (1995). Aportacions al coneixement dels gravats prehistòrics dels massissos de les Gavarres i de Begur (Girona). 77–90.
20.
Sierra, Jorge, A Grañena, Francesc Bosch, et al.. (1992). Mitoxantrone and intermediate‐dose cytosine arabinoside for poor‐risk acute leukemias: Response to treatment and factors influencing outcome. Hematological Oncology. 10(6). 301–309. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026